Jonathan B. Siegel - Aug 14, 2023 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Director
Signature
/s/ Lisa A. Conte, Attorney-in-Fact
Stock symbol
JAGX
Transactions as of
Aug 14, 2023
Transactions value $
$0
Form type
4
Date filed
8/14/2023, 04:53 PM
Previous filing
May 19, 2023
Next filing
Oct 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAGX Common Stock Award $0 +68.6K +5250.23% $0.00 69.9K Aug 14, 2023 Direct
holding JAGX Common Stock 59 Aug 14, 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held directly by JBS Healthcare Ventures LLC. Mr. Siegel, by virtue of his position as the sole member of JBS Healthcare Ventures LLC, may be deemed to beneficially own the securities held by JBS Healthcare Ventures LLC for purposes of Section 16.